One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021
Matthew E. Oster, MD, MPH; David K. Shay, MD, MPH; John R. Su, MD, PhD, MPH; et al.
doi : 10.1001/jama.2021.24110
Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel
Avishay Spitzer, MD; Yoel Angel, MD, MBA; Or Marudi, MSc; et al.
doi : 10.1001/jama.2021.23641
Population-Based Penetrance of Deleterious Clinical Variants
Iain S. Forrest, BS; Kumardeep Chaudhary, PhD; Ha My T. Vy, PhD; et al.
doi : 10.1001/jama.2021.23686
Hip Fracture Surgery Volumes Among Individuals 65 Years and Older During the COVID-19 Pandemic
Kanu Okike, MD, MPH; Priscilla H. Chan, MS; Ronald A. Navarro, MD; et al.
doi : 10.1001/jama.2021.23761
Aspirin Use for Preeclampsia Prevention Among Women With Prepregnancy Diabetes, Obesity, and Hypertension
Joel G. Ray, MD, MSc; Kasim E. Abdulaziz, MSc; Howard Berger, MD; et al.
doi : 10.1001/jama.2021.22749
Screening for Atrial FibrillationUS Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force
doi : 10.1001/jama.2021.23732
Screening for Atrial FibrillationUpdated Evidence Report and Systematic Review for the US Preventive Services Task Force
Leila C. Kahwati, MD, MPH; Gary N. Asher, MD, MPH; Zachary O. Kadro, ND; et al.
doi : 10.1001/jama.2021.21811
The Rational Diagnostician and Achieving Diagnostic Excellence
Pat Croskerry, MD, PhD
doi : 10.1001/jama.2021.24988
Winter of Omicron—The Evolving COVID-19 Pandemic
Carlos del Rio, MD; Saad B. Omer, MBBS, MPH, PhD; Preeti N. Malani, MD, MSJ
doi : 10.1001/jama.2021.24315
Shifting to Serious Illness Communication
Juliet Jacobsen, MD; Rachelle Bernacki, MD; Joanna Paladino, MD
doi : 10.1001/jama.2021.23695
The Dysfunctional Health Benefits Market and Implications for US Employers and Employees
David Scheinker, PhD; Arnold Milstein, MD; Kevin Schulman, MD
doi : 10.1001/jama.2021.23258
Booster Vaccination to Reduce SARS-CoV-2 Transmission and Infection
Anna Wald, MD, MPH
doi : 10.1001/jama.2021.23726
Screening for Atrial Fibrillation—More Data Still Needed
Philip Greenland, MD
doi : 10.1001/jama.2021.23727
Tixagevimab and Cilgavimab (Evusheld) for Pre-Exposure Prophylaxis of COVID-19
doi : 10.1001/jama.2021.24931
Highlights From the American Heart Association’s Scientific Sessions—ApoB as a Risk Marker, an Oral PCSK9 Inhibitor, and Aspirin and Dementia
Jennifer Abbasi
doi : 10.1001/jama.2021.21397
Fall Influenza A(H3N2) Outbreak at a Midwestern University
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.23854
CDC Establishes Global Networks to Combat Antimicrobial Resistance
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.24379
Financial Incentives Help People Quit Smoking During Pregnancy
Anita Slomski
doi : 10.1001/jama.2021.23106
Teriflunomide Reduced Lesions in Pediatric Multiple Sclerosis
Anita Slomski
doi : 10.1001/jama.2021.25109
Increased Use of Medicare Telehealth During the Pandemic
Melissa Suran, PhD, MSJ
doi : 10.1001/jama.2021.23332
Coverage of COVID-19 Vaccine Counseling for Children and Youths
Melissa Suran, PhD, MSJ
doi : 10.1001/jama.2021.25080
Oncostatin M Cytokine Associated With Chronic Itch
Melissa Suran, PhD, MSJ
doi : 10.1001/jama.2021.25081
Combined Varenicline With Nicotine Patch and Extended Duration of Therapy for Smoking Cessation
Adam Edward Lang, PharmD
doi : 10.1001/jama.2021.22661
Combined Varenicline With Nicotine Patch and Extended Duration of Therapy for Smoking Cessation—Reply
Timothy B. Baker, PhD; Michael C. Fiore, MD, MPH, MBA
doi : 10.1001/jama.2021.22664
Clinical Challenge About Retinal Artery Thrombosis and Aortic Valve Vegetations
William A. Schiavone, DO
doi : 10.1001/jama.2021.22905
Clinical Challenge About Retinal Artery Thrombosis and Aortic Valve Vegetations—Reply
Miroslav Sekulic, MD, MA; Alan H. Markowitz, MD; Shree K. Kurup, MD
doi : 10.1001/jama.2021.22908
Association of Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome
Hai-Feng Li, MD, PhD; Shi-Min Hu, PhD; Ming Lv, MD, PhD
doi : 10.1001/jama.2021.23003
Presumptive Guillain-Barré Syndrome Associated With Receipt of the Ad26.COV2.2.S COVID-19 Vaccine—Reply
Emily Jane Woo, MD, MPH; Rositsa B. Dimova, PhD; Adamma Mba-Jonas, MD, MPH
doi : 10.1001/jama.2021.23006
